Isolated erythrocytosis in V617F negative patients with JAK2 exon 12 mutations: Report of a new mutation

American Journal of Hematology

Volumn 84, Issue 4, 2009, Pages 258-260

  Bernardi, Martina ^a   Ruggeri, Marco ^a   Albiero, Elena ^a   Madeo, Domenico ^a   Rodeghiero, Francesco ^a  

^a SAN BORTOLO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ERYTHROPOIETIN; HEMOGLOBIN; JANUS KINASE 2; RETICULIN;

ACUTE LEUKEMIA; ALLELE; AMPLICON; BONE MARROW BIOPSY; CARDIOVASCULAR DISEASE; CELL PROLIFERATION; ERYTHROCYTOSIS; ERYTHROID CELL; EXON; GENE DELETION; GENE INSERTION SEQUENCE; GENE MUTATION; GENE SEQUENCE; GENOTYPE; GRANULOCYTE; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HETERODUPLEX ANALYSIS; HUMAN; HYPERPLASIA; LETTER; LEUKOCYTE; LEUKOCYTE COUNT; LEUKOCYTOSIS; MEGAKARYOPOIESIS; MYELOFIBROSIS; MYELOPROLIFERATIVE DISORDER; PHLEBOTOMY; POLYCYTHEMIA VERA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DOMAIN; RISK FACTOR; SPLEEN; SPLENOMEGALY; THROMBOCYTE COUNT; THROMBOSIS; ADOLESCENT; ADULT; AGED; CASE REPORT; COHORT ANALYSIS; DIFFERENTIAL DIAGNOSIS; ENZYMOLOGY; FEMALE; GENETICS; MALE; MIDDLE AGED; MUTATION; PHENOTYPE; POLYCYTHEMIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; DIAGNOSIS, DIFFERENTIAL; EXONS; FEMALE; HUMANS; JANUS KINASE 2; MALE; MIDDLE AGED; MUTATION; PHENOTYPE; POLYCYTHEMIA; POLYCYTHEMIA VERA; YOUNG ADULT;

EID: 64549128133     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21357     Document Type: Letter

References (19)

1. Scott LM, Tong W, Levine RL, et al. Jak2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis. N Engl J Med 2007;356:459-468.
2. Colaizzo D, Amitrano L, Tiscia GL, et al. A new JAK2 gene mutation in patients with polycythemia vera and splanchnic vein thrombosis. Blood 2007;110:2768-2769.
3. Percy MJ, Scott LM, Erber WN, et al. The frequency of JAK2 exon 12 mutations in idiophatic erythrocytosis patients with low serum erythropoietin levels. Haematologica 2007;92:1607-1614.
4. Pardanani A, Lasho TL, Finke C, et al. Prevalence and clinicopathological correlates of JAK exon 12 mutations in JAK2V617F-negative polycythemia vera. Leukemia 2007;21:1960-1963.
5. Williams DM, Kim AH, Rogers O, et al. Phenotypic variations and new mutations in JAK2 V617F-negative polycythemia vera, erythrocytosis, and idiopathic myelofibrosis. Exp Hematol 2007;35:1641-1646.
6. Martìnez-Avilés L, Besses C, Larran AA, et al. JAK2 exon 12 mutations in polycythemia vera or idiopathic erythrocytosis. Haematologica 2007;92:1717-1718.
7. Li S, Kralovics R, De Libero G, et al. Clonal heterogeneity in polycythemia vera patients with JAK2 exon 12 and JAK2-V617F mutations. Blood 2008;111:3863-3866.
8. Pietra D, Li S, Brisci A, et al. Somatic mutations of JAK2 exon 12 in patients with JAK2 (V617)-negative myeloproliferative disorders. Blood 2008;111:1686-1689.
9. Kouroupi E, Zoi K, Parquet N, et al. Mutations in exon 12 of JAK2 are mainly found in JAK2 V617F-negative polycythaemia vera patients. Br J Haematol 2008;142:668-680.
10. Butcher CM, Hahn U, To LB, et al. Two novel JAK2 exon 12 mutations in JAK2V617F-negative polycythaemia vera patients. Leukemia 2008;22:870-873.
11. Albiero E, Madeo D, Ruggeri M, et al. Loss of the JAK2 intramolecular auto-inhibition mechanism is predicted by structural modeling of a novel exon 12 insertion mutation in a case of idiophatic erythrocytosis. Br J Haematol 2008;142:986-990.
12. Baxter EJ, Scott LM, Campbell PJ, et al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet 2005;365:1054-1061.
13. Albiero E, Bernardi M, Madeo D, et al. A new TMHA-DHPLC assay for the rapid mutation screening of JAK2 exon 14 in myeloproliferative disorders. Am J Hematol 2008;83:603-604.
14. Tefferi A, Thiele J, Orazi A, et al. Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia and primary myelofibrosis: Recommendations from an ad hoc international expert panel. Blood 2007;110:1092-1097.
15. Pearson TC. Evaluation of diagnostic criteria in polycythemia vera. Semin Hematol 2001;38:21-24. (Pubitemid 32220623)
16. Landolfi R, Di Gennaro L, Barbui T, et al. Leukocytosis as a major thrombotic risk factor in patients with polycythemia vera. Blood 2007;109:2446-2452.
17. Austin SK, Lambert JR. The JAK V617F mutation and thrombosis. Br J Haematol 2008;143:307-320.
18. Finazzi G, Caruso V, Marchioli R, et al. Acute leukemia in polycythemia vera: Analysis of 1638 patients enrolled in a prospective observational study. Blood 2005;105:2664-2670.
19. Finazzi G, Ruggeri M, Rodeghiero F, et al. Second malignancies in patients with essential thrombocythemia treated with busulphan and hydroxyurea: Long-term follow-up of a randomized clinical trial. Br J Haematol 2000;110:577-583.